Citation Impact

Citing Papers

Immunopathogenic Mechanisms of HIV Infection
1996 Standout
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
1999 Standout
Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals
1989 Nature
HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
1990 Standout
Host factors and the pathogenesis of HIV-induced disease
1996 Nature
Cell-Mediated Immune Response to Human Immunodeficiency Virus (HIV) Type 1 in Seronegative Homosexual Men with Recent Sexual Exposure to HIV-1
1992
Recognition Requirements for the Activation, Differentiation and Function of T‐Helper Cells Specific for Class I MHC Alloantigens
1987
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
1993 StandoutNature
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
Dynamics of HIV infection of CD4+ T cells
1993
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
1993 StandoutNature
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis
1991
HIV-1 antibody serum negativity with urine positivity
1993 StandoutNobel
Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans
1988 Nature
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
1988
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
1997 StandoutNature
Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.
1990
HIV as the cause of AIDS
1996 StandoutNobel
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection
1991
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
1995 StandoutNature
Changing Virus‐Host Interactions in the Course of HIV‐1 Infection
1994
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Inhibition of NF-κB by Sodium Salicylate and Aspirin
1994 StandoutScience
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
1997 StandoutNatureNobel
Regulation by HIV Rev depends upon recognition of splice sites
1989 StandoutNobel
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
1995
Decay characteristics of HIV-1-infected compartments during combination therapy
1997 StandoutNature
Effect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1
1996
Changes in thymic function with age and during the treatment of HIV infection
1998 StandoutNature
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates
1988
LONG LATENCY PRECEDES OVERT SEROCONVERSION IN SEXUALLY TRANSMITTED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
1987
In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter.
1987
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
1991 StandoutNobel
Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.
1987
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation.
1996 StandoutNobel
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture
1991
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Human T-lymphotropic retroviruses
1985 Nature
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
1986 StandoutScience
Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.
1991
Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
1991
Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI
1997
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
1988 StandoutScienceNobel
Phenotypic Analysis of Antigen-Specific T Lymphocytes
1996 StandoutScience
Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection.
1992
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.
1990
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
1988 StandoutScience
Lymphadenopathy-Associated-Virus Infection and Acquired Immunodeficiency Syndrome
1986 StandoutNobel
Cytokine-Induced Expression of HIV-1 in a Chronically Infected Promonocyte Cell Line
1987 Science
Antibody to Human T-Lymphotropic Virus Type III in Wives of Hemophiliacs
1985
Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1.
1991
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase.
1993 StandoutNobel
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.
1992
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.
1994 StandoutNobel
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
1998 StandoutNobel
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
TRANSMISSIBILITY OF HUMAN IMMUNODEFICIENCY VIRUS IN HAEMOPHILIC AND NON-HAEMOPHILIC CHILDREN LIVING IN A PRIVATE SCHOOL IN FRANCE
1986 StandoutNobel
Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III.
1985
Growth Factors and Cancer
1991 StandoutScience
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for Therapy
1993 Science
A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses
1985
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
Laboratory diagnostics for HIV infection.
2010
Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.
1990
Pathogenesis of Infection with Human Immunodeficiency Virus
1987
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
1988 StandoutScience
HIV replication in CD4+T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines
1996 StandoutNobel
A Cell Culture Model for T Lymphocyte Clonal Anergy
1990 StandoutScience
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
1997 StandoutScience
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.
1989
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
1997 StandoutScience
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection
1987 StandoutNobel
Dendritic Cells Exposed to Human Immunodeficiency Virus Type-1 Transmit a Vigorous Cytopathic Infection to CD4 + T Cells
1992 StandoutScienceNobel
Apoptosis in AIDS
1993 StandoutScienceNobel
Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.
1992
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
1992
Prospects for the Future
2002 StandoutScienceNobel
Strategies for antiviral therapy in AIDS
1987 Nature
Mechanisms and Genes of Cellular Suicide
1995 StandoutScience
Inhibition of Antigen-Induced Lymphocyte Proliferation by Tat Protein from HIV-1
1989 Science
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1
1994 StandoutNobel

Works of R Redfield being referenced

HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONS
1984
Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
1986
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
1986
Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
1986
Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes: implications for therapy.
2001
EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO
1985
Impaired antibody-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome.
1986
Rankless by CCL
2026